Mount Sinai’s Research Arm Using Data Analytics to Address Health Inequities | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Mount Sinai’s Research Arm Using Data Analytics to Address Health Inequities

October 25, 2016
by Heather Landi
| Reprints

The Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai is partnering with satellite imaging and data analytics company DigitalGlobe to create the Health Equity Atlas Initiative (ATLAS), a platform that standardizes and maps population data in order to generate insights that address health inequities.

According to Prabhjot Singh, M.D., Ph.D., director, The Arnhold Institute for Global Health, and chair, Department of Health System Design and Global Health, Icahn School of Medicine at Mount Sinai, the goal of the partnership is to address structural inequities affecting healthcare delivery and response to vulnerable populations. The platform is now being tested in active Arnhold Institute projects in Ghana, Guatemala, and New York City. 

“Whether we’re talking about the Zika virus epidemic in the Americas and Caribbean, an outbreak of Ebola virus disease in a rural West African community, or chronic conditions like asthma or diabetes in East Harlem, information gaps exacerbate vulnerabilities to health crises, potentially transforming blind spots to hot spots,” Singh said.

ATLAS highlights blind spots in demographic and health information by analyzing inputs from frontline health workers and high-accuracy, high-resolution satellite images from DigitalGlobe, according to a press release. While the data engine can house existing demographic health surveys and infrastructure assessments, it is optimized for communities where information sources are out of date or absent.

DigitalGlobe operates commercial earth imaging satellites, which collect more than 3 million square kilometers of Earth imagery daily. Leveraging cloud computing and machine learning algorithms, DigitalGlobe's Geospatial Big Data platform, GBDX, streamlines data processing and analytics to extract useful information from the imagery-at scale.

Working with the imaging and data analytics vendor, Arnhold Institute researchers will be able to understand where the most vulnerable communities are, how to reach them, and what interventions are working, according to the press release.

Other technology companies working with The Arnhold Institute in developing the Health Equity Atlas include software company Dimagi and Medic Mobile, a mobile health company.

 

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Study: Use of EHRs Does Not Reduce Administrative Costs

A recent study by Duke University and Harvard Business School researchers found that costs for processing a single bill ranged from $20 for a primary care visit to $215 for an inpatient surgical procedure, or up to 25 percent of revenue.

Kibbe to Step Down as CEO of DirectTrust

David Kibbe, M.D., M.B.A., announced he would step down as president and CEO of DirectTrust at the end of the year.

Sequoia Project Exec Appointed to HITAC’s Interoperability Task Force

The Sequoia Project’s CIO/CTO, Eric Heflin, has been appointed to the Health Information Technology Advisory Committee’s (HITAC) U.S. Core Data for Interoperability Task Force (USCDI).

Healthcare Orgs Report Improvements in Quality, Cost Using Data and Analytics

In 2017, nearly three dozen organizations ranging in size from small community hospitals to some of the nation’s largest integrated delivery systems documented 125 improvements in quality, cost and efficiency using technology and improvement processes.

Consortium to Promote Implementation of a FHIR Genomics Platform

At this week’s HL7 Genomics Conference in Washington, D.C., a new group was introduced to promote implementation of a FHIR Genomics platform.

Cedars-Sinai Collaborates on Organs-on-Chip Precision Medicine Project

Scientists at Los Angeles-based Cedars-Sinai, in partnership with biotechnology startup Emulate, are pioneering a Patient-on-a-Chip program to help predict which disease treatments would be most effective based on a patient's genetic makeup and disease variant.